Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Disclosure of Change in Interest of Director - Dr. Lee Mun Kam Bernard

Issuer & Securities

Announcement Title: Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer
Date &Time of Broadcast: 08-Apr-2022 19:55:16
Status: New
Announcement Sub Title: Disclosure of Change in Interest of Director - Dr. Lee Mun Kam Bernard
Announcement Reference: SG220408OTHRLNOL
Submitted By (Co./ Ind. Name): Dr. Lee Mun Kam Bernard
Designation: Executive Director and Chief Executive Officer
Description (Please provide a detailed description of the event in the box below - Refer to the Online help for the format): Please refer to the attached Form.

Singapore Paincare Holdings Limited (the "Company") was listed on Catalist of the Singapore Exchange Securities Trading Limited (the "SGX-ST") on 30 July 2020. The initial public offering of the Company was sponsored by Novus Corporate Finance Pte. Ltd. (the "Sponsor").

This announcement has been prepared by the Company and reviewed by the Sponsor, in compliance with Rule 226(2)(b) of the SGX-ST Listing Manual Section B: Rules of Catalist.

This announcement has not been examined or approved by the SGX-ST and the SGX-ST assumes no responsibility for the contents of this announcement, including the correctness of any of the statements or opinions made, or reports contained in this announcement.

The contact person for the Sponsor is Mr. Pong Chen Yih, Chief Operating Officer, 7 Temasek Boulevard, #18-03B Suntec Tower 1, Singapore 038987, telephone (65) 6950 2188.

Person(s) giving notice: Director/Chief Executive Officer who may also be a substantial shareholder/unitholder (Form 1)
Date of receipt of notice by Listed Issuer: 08/04/2022

if you are unable to view the above file, please click the link below.

Total size =150K